Respiratory Training in Hemodialysis Patients
Effects of Respiratory Muscle Training in Muscle Force, Functional Capacity and Quality of Life in Hemodialysis Patients
1 other identifier
interventional
46
1 country
1
Brief Summary
Patients with chronic kidney disease in hemodialysis have complex syndrome with diverse effects on cardiovascular, nervous, respiratory, musculoskeletal, immune and endocrine-metabolic systems. With regard to the musculoskeletal structure, there is progressive muscular loss with consequent increase in muscle weakness, limited resistance, exercise intolerance and fatigue, as well as functional and morphological abnormalities characteristic of uremic myopathy. Respiratory muscles are also affected as a result of uremic myopathy, with decreased strength and resistance. Objective: to analyze the impact of respiratory muscle training on muscle strength, functional capacity and quality of life of patients with chronic kidney disease on hemodialysis. Method: This is a prospective, randomized study involving 46 patients followed by the dialysis unit of a university hospital, over 18 years old, of both genders who underwent hemodialysis for more than six months and who signed the informed consent form. Patients will be allocated into two groups: respiratory muscle training with PowerBreath and control. All will be evaluated for demographic data, respiratory muscle strength, lung function, functional capacity and quality of life. The intervention group will perform three months of intradialytic training of a physical therapy protocol with PowerBreath. Both groups will be reevaluated after three months.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Apr 2017
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 12, 2017
CompletedFirst Submitted
Initial submission to the registry
May 12, 2017
CompletedFirst Posted
Study publicly available on registry
May 15, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
April 30, 2019
CompletedJuly 29, 2022
November 1, 2019
6 months
May 12, 2017
July 27, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Manovacuometry
RESPIRATORY MUSCLE FORCE
Change from baseline in respiratory muscle force at 3 months
Spirometry
Pulmonary Function
Change from baseline in Pulmonary Function at 3 months
Distance in six-minute walk test
analysis of distance
change from baseline in distance at 3 months
Quality of life questionnaire
Analysis of the quality of life
change from baseline in quality of life at 3 months
HRR1
heart rate recovery
change from HR six minute walk test and seven minute
Study Arms (2)
Respiratory muscle training
EXPERIMENTAL\- three months of intradialytic training of a physical therapy protocol with PowerBreath.
Control
NO INTERVENTIONNo intervention
Interventions
The intervention group will perform three months of intradialytic training of a physical therapy protocol with PowerBreath
Eligibility Criteria
You may qualify if:
- Patients with chronic kidney disease undergoing hemodialysis for more than 6 months Both genders
- ged 18 years or older
- clinically stable
- who agreed to participate in the study by signing a free informed consent form
You may not qualify if:
- Patients with previous or current myoarticular or neurological disease;
- That require some urgent or elective surgical intervention during the protocol;
- Any cardiac decompensation such as arrhythmias, systolic blood pressure greater than 200mmHg or less than 60mmHg, diastolic blood pressure greater than 120mmHg or less than 40mmHg;
- Decompensated diabetes mellitus and acute systemic infection
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Santa Casa of Sao Paulo Medical School
São Paulo, São Paulo, 01221-020, Brazil
Related Publications (3)
Stevens PE, Levin A; Kidney Disease: Improving Global Outcomes Chronic Kidney Disease Guideline Development Work Group Members. Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline. Ann Intern Med. 2013 Jun 4;158(11):825-30. doi: 10.7326/0003-4819-158-11-201306040-00007.
PMID: 23732715BACKGROUNDLevey AS, Atkins R, Coresh J, Cohen EP, Collins AJ, Eckardt KU, Nahas ME, Jaber BL, Jadoul M, Levin A, Powe NR, Rossert J, Wheeler DC, Lameire N, Eknoyan G. Chronic kidney disease as a global public health problem: approaches and initiatives - a position statement from Kidney Disease Improving Global Outcomes. Kidney Int. 2007 Aug;72(3):247-59. doi: 10.1038/sj.ki.5002343. Epub 2007 Jun 13.
PMID: 17568785BACKGROUNDKaltsatou A, Sakkas GK, Poulianiti KP, Koutedakis Y, Tepetes K, Christodoulidis G, Stefanidis I, Karatzaferi C. Uremic myopathy: is oxidative stress implicated in muscle dysfunction in uremia? Front Physiol. 2015 Mar 30;6:102. doi: 10.3389/fphys.2015.00102. eCollection 2015.
PMID: 25870564BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PHD
Study Record Dates
First Submitted
May 12, 2017
First Posted
May 15, 2017
Study Start
April 12, 2017
Primary Completion
September 30, 2017
Study Completion
April 30, 2019
Last Updated
July 29, 2022
Record last verified: 2019-11